resectable colon cancer
Showing 1 - 25 of >10,000
Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)
Not yet recruiting
- Colonic Neoplasms
- Dostarlimab
- +2 more
- (no location specified)
May 3, 2023
MSI-H Trial in Guangzhou (IBI310, Radical surgery, Sintilimab)
Not yet recruiting
- MSI-H
- IBI310
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 26, 2023
Stage, Colon Cancer, Stage I-III Colon Cancer, Stage IV Colon Cancer With Resectable Liver Metastases Trial in Boston (Vitamin
Recruiting
- Stage, Colon Cancer
- +2 more
- Vitamin D3
- Placebo
-
Boston, MassachusettsDana-Farber Cancer Institute
May 18, 2022
Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer Trial in Houston (Tecentriq 1200 MG in 20 ML Injection +
Not yet recruiting
- Stage I Colon Cancer
- +2 more
- Tecentriq 1200 MG in 20 ML Injection + Capecitabine 1000 mg/m2 + Oxaliplatin 130 mg/m2
- +2 more
-
Houston, TexasBaylor College of Medicine
May 22, 2023
Viewpoints on Social Representations and Rationale Concerning
Terminated
- Non-resectable Metastatic Cancer of the Lung
- +7 more
- Interviews
- Questionnaires
-
Dijon, FranceChu Dijon Bourogne
Apr 14, 2022
Colon Cancer Stage II, Colon Cancer Stage III Trial in Guangzhou (neoadjuvant chemoI, Colectomy, adjuvant chemo)
Recruiting
- Colon Cancer Stage II
- Colon Cancer Stage III
- neoadjuvant chemotherapyI
- +2 more
-
Guangzhou, Guangdong, China651 Dongfeng Road East
Jan 14, 2022
Liver Metastasis Colon Cancer Trial in Madison (Living Donor Liver Transplantation)
Recruiting
- Liver Metastasis Colon Cancer
- Living Donor Liver Transplantation
-
Madison, WisconsinUniversity of Wisconsin School of Medicine and Public Health
Jul 27, 2022
Liver Metastasis Colon Cancer, Colorectal Cancer Trial in Bologna (Liver Transplantation)
Recruiting
- Liver Metastasis Colon Cancer
- Colorectal Cancer
- Liver Transplantation
-
Bologna, ItalyIRCCS Azienda Ospedaliero - Universitaria di Bologna
Jan 7, 2022
Colon Adenocarcinoma, Liver Metastasis Colon Cancer Trial in Modena (Living donor liver transplant)
Recruiting
- Colon Adenocarcinoma
- Liver Metastasis Colon Cancer
- Living donor liver transplant
-
Modena, MO, ItalyAzienda Ospedaliero Universitaria di Modena
Jan 18, 2022
Liver Metastases, Liver Metastasis Colon Cancer, Colorectal Cancer Trial in Tampa (DNX-2440)
Recruiting
- Liver Metastases
- +10 more
- DNX-2440
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute, Inc.
Mar 28, 2022
Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive
Recruiting
- Malignant Abdominal Neoplasm
- +26 more
- Cisplatin
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Colon Carcinoma Metastatic in the Liver, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Atlanta, Rochester
Active, not recruiting
- Colon Carcinoma Metastatic in the Liver
- +13 more
- Anti-SEMA4D Monoclonal Antibody VX15/2503
- +3 more
-
Atlanta, Georgia
- +3 more
Dec 15, 2021
Advanced Solid Tumors, Digestive System Tumors, Pancreatic Cancer Resectable Trial in Beijing (IM96 CAR-T cells)
Recruiting
- Advanced Solid Tumors
- +3 more
- IM96 CAR-T cells
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Mar 10, 2022
Liver Metastasis, Colon Cancer Trial in United Kingdom (Icosapent Ethyl, Placebo)
Recruiting
- Liver Metastasis
- Colon Cancer
- Icosapent Ethyl
- Placebo
-
Oxford, Oxfordshire, United Kingdom
- +12 more
Nov 7, 2022
Colorectal Tumor Trial (Reduced-port laparoscopic surgery, conventional laparoscopic surgery)
Not yet recruiting
- Colorectal Neoplasm
- Reduced-port laparoscopic surgery
- conventional laparoscopic surgery
- (no location specified)
Jul 12, 2023
ctDNA in Resectable and Borderline Resectable Pancreatic Cancer
Recruiting
- Pancreatic Cancer
- SIGNATERA™ ctDNA testing
-
Fairfax, VirginiaInova Schar Cancer Institute
Oct 26, 2022
Candidates for Neoadjuvant Treatment in Resectable Pancreatic
Completed
- Pancreatic Cancer
- Neoadjuvant
- Neoadjuvant treatment
- (no location specified)
Nov 9, 2023
Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)
Recruiting
- Gastric Cancer
- sintilimab+metronomic PLOF
-
Shanghai, ChinaHuashan Hospital, Fudan University
Sep 22, 2023
Lung Cancer Trial (Sacituzumab Govitecan, Pembrolizumab)
Not yet recruiting
- Lung Cancer
- Sacituzumab Govitecan
- Pembrolizumab
- (no location specified)
Sep 20, 2023
Clinical Significance of Marginal Acute Inflammation for Stage
Completed
- Inflammation
- Colon Cancer
- MAI detection
- (no location specified)
Nov 11, 2023
Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,
Not yet recruiting
- Pancreatic Cancer, Stage IB
- +3 more
- sintilimab
- +2 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Jan 4, 2023
Colon Cancer Trial in San Antonio (PalloV-CC)
Recruiting
- Colon Cancer
- PalloV-CC
-
San Antonio, TexasClinical Associates of Research Therapeutics of America
Sep 14, 2022